| Filed On | Filing |
|---|---|
| 13 Nov 2026 | SCHEDULE 13G |
| 10 Nov 2026 | SCHEDULE 13G |
| 06 Nov 2026 | SCHEDULE 13G/A |
| 05 Nov 2026 | SCHEDULE 13G/A |
| 05 Nov 2026 |
8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement
Avalo Therapeutics, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell from time to time through Jefferies LLC, as sales agent and/or principal (the “Agent”), shar... |
| 05 Nov 2026 | S-3ASR |
| 05 Nov 2026 | 424B5 |
| 05 Nov 2026 | 10-Q |
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition
WAYNE, Pa., Nov. 5, 2026 – Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical-stage biotechnology company focused on developing therapies targeting the IL-1β pathway for immune-mediated inflammatory diseases, today reported financial re... |
| 29 Oct 2026 | SCHEDULE 13G |
| 02 Oct 2026 |
Form 4: Jain Rita, Director
Granted 1,322 Stock Option (Right to Buy) ($16.2K) |
| 02 Oct 2026 |
Form 4: Lind Kevin Robert, Director
Granted 1,352 Stock Option (Right to Buy) ($16.6K) |
| 02 Oct 2026 |
Form 4: Philip Ron M, Director
Granted 1,109 Stock Option (Right to Buy) ($13.6K) |
| 18 Sep 2026 |
Form 4: Sullivan Christopher Ryan, Chief Financial Officer
Received 12,394 shares by exercise or conversion ($122K) · Sold 12,394 shares ($202K) |
| 11 Sep 2026 |
Form 4: Sullivan Christopher Ryan, Chief Financial Officer
Received 10,185 shares by exercise or conversion ($81.9K) · Sold 10,185 shares ($179K) |
| 01 Sep 2026 |
Form 4: Doyle Mittie, Chief Medical Officer
Received 679 shares by exercise or conversion ($5.46K) · Sold 679 shares ($13.6K) |
| 19 Aug 2026 |
Form 4: Sullivan Christopher Ryan, Chief Financial Officer
Received 40,821 shares by exercise or conversion ($403K) · Sold 41,694 shares ($828K) · Received 31,031 shares by exercise or conversion ($307K) · 1 more |
| 19 Aug 2026 |
Form 4: Doyle Mittie, Chief Medical Officer
Received 1,000 shares by exercise or conversion ($12.7K) · Sold 1,000 shares ($20K) |
| 18 Aug 2026 | 144 |
| 17 Aug 2026 | 144 |
Loading...